summary
Introduced
03/29/2021
03/29/2021
In Committee
03/29/2021
03/29/2021
Crossed Over
Passed
Dead
12/31/2022
12/31/2022
Introduced Session
192nd General Court
Bill Summary
Relative to the issuing of the initial prescription of Schedule II controlled dangerous substances or other opioid pain relievers. Mental Health, Substance Use and Recovery.
AI Summary
This bill amends the existing law to require practitioners to discuss the risks associated with prescribing Schedule II controlled substances or other opioid pain relievers with patients, or their parents/guardians if the patient is under 18 and not an emancipated minor, before issuing the initial prescription and again before the third prescription in a course of treatment. The discussion must cover the risks of addiction and overdose, the reason for the prescription, alternative treatments, and the risks of dependence and using the medication improperly or with other central nervous system depressants. Practitioners must make a note in the patient's medical record that this discussion has occurred. The bill provides exceptions for patients in active cancer treatment, hospice/palliative care, long-term care facilities, or receiving treatment for substance abuse or opioid dependence.
Committee Categories
Health and Social Services
Sponsors (7)
Steven Howitt (R)*,
Colleen Garry (D),
Jim Hawkins (D),
Matt Muratore (R),
Mike Soter (R),
Timothy Whelan (R),
Steve Xiarhos (R),
Last Action
Accompanied a study order, see H5225 (on 09/22/2022)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Document Type | Source Location |
---|---|
State Bill Page | https://malegislature.gov/Bills/192/H2101 |
Bill | https://malegislature.gov/Bills/192/H2101.pdf |
Loading...